-

New Study finds Volumetric Absorptive Micro-Samplers (VAMS) Prove to be Useful Self-Collection Tools for Assessing Human Exposure to PFAS

LUXEMBOURG--(BUSINESS WIRE)--The American Chemical Society’s Environmental Science and Technology journal recently published a study, “A Self-Collection Blood Test for PFASs: Comparing Volumetric Micro-Samplers with a Traditional Serum Approach” which reports a test developed by Eurofins Environment Testing is a viable self-collection tool for assessing human exposure to PFAS. This method effectively quantifies PFAS in whole blood samples collected by volumetric micro samplers (VAMS).

PFAS, short for per- and polyfluoroalkyl substances, are a class of very stable compounds with unique characteristics making them largely unsusceptible to degradation. Some PFAS accumulate and persist in the environment and in humans. Accumulation of some PFAS in blood has been linked to several negative health outcomes, leading to a need for more epidemiological research.

Historically, serum has been used to conduct biomonitoring of PFAS. Traditional blood collection (serum or plasma) for biomonitoring can be costly and challenging to coordinate and requires the support of a trained phlebotomist. Recent studies have indicated whole blood, collected easily with VAMS, to be a better approach for assessing exposure to a broader suite of PFAS.

Results from the American Chemical Society’s Environmental Science and Technology journal’s study included the sampling and testing of individuals through traditional serum and self-collected VAMS. PFAS levels in serum were highly correlated with measurements in capillary VAMS, indicating that VAMS are useful self-collection tools for assessing human exposure to PFAS.

"This research study is a critical effort, as it provides us with confidence that self-collected blood samples provide just as good – if not, in some cases, better – data on human exposure,” said Christopher P. Higgins, a co-author of the study and University Distinguished Professor of Civil and Environmental Engineering at Colorado School of Mines. “Just as importantly, though, these are much easier to collect than traditional serum samples, and thus this really opens the door for bigger-scale PFAS exposure assessment efforts.”

Self-collected blood samples can help support large scale biomonitoring programs and epidemiologic studies providing a promising solution to several obstacles encountered in biomonitoring studies.

This study was co-authored by Andrew Patterson, Thep Phomsopha, and Eric Redman, all scientists from within the Eurofins Environment Testing network of companies in the USA. Additional co-authors include Courtney Carignan and Rachel Bauer with Michigan State University and Heather Stapleton with Duke University.

Read the published paper in Environmental Science and Technology here.

About Eurofins Environment Testing – USA

The Eurofins environmental laboratories network in the US performs analysis of drinking water, groundwater, seawater, soil, air, and tissue using state-of-the-art analytical methods to assess quality and impact on health and the environment.

Contacts

Further information:
Brooke Maharg
Brooke.Maharg@ET.EurofinsUS.com

Eurofins Environment Testing – USA

BOURSE:ERF

Release Versions

Contacts

Further information:
Brooke Maharg
Brooke.Maharg@ET.EurofinsUS.com

More News From Eurofins Environment Testing – USA

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Financial highlights in H1 2026 Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives. Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 13th July to 17th July 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Weekly report on share repurchases from 13th July to 17th July 2026   Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/07/2026 FR0014000MR3 15 000 69.1984 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/07...

Eurofins Agrees to Acquire Element Materials Technology’s Life Sciences Testing Services Business in North America

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (EUFI.PA) (Paris:ERF), a global scientific leader in bioanalytical testing, has reached an agreement with Element Materials Technology (“Element”) to acquire its Life Sciences Testing Services business in North America, for an enterprise value of $400m. The transaction is subject to customary conditions, including regulatory approvals, and is expected to close in Q4 2026. Element’s North America Life Sciences Testing Services inc...
Back to Newsroom